Evogene Ltd. EBITDA for the year ending December 31, 2024: USD -15.48 M

Evogene Ltd. EBITDA is USD -15.48 M for the year ending December 31, 2024, a -33.46% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Evogene Ltd. EBITDA for the year ending December 31, 2023 was USD -23.26 M, a -13.88% change year over year.
  • Evogene Ltd. EBITDA for the year ending December 31, 2022 was USD -27.01 M, a -3.13% change year over year.
  • Evogene Ltd. EBITDA for the year ending December 31, 2021 was USD -27.88 M, a 20.13% change year over year.
  • Evogene Ltd. EBITDA for the year ending December 31, 2020 was USD -23.21 M, a 26.16% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)